Hashish Europa London 2025, Europe’s premier discussion board connecting the visionaries, policymakers, and enterprise leaders shaping the hashish {industry}, is now lower than two weeks away.
As Europe’s hashish market enters a brand new chapter of progress, with speedy advances in medical hashish, progressive regulatory shifts and ongoing battles to liberalise hashish happening throughout the continent, our sponsors stay on the core of its evolution.
We’re proud to be supported by a few of the hashish {industry}’s most forward-thinking and influential companies. Their backing helps create an atmosphere the place innovation thrives, significant connections are made, and daring concepts can take form.
Be part of us in London on June 25-26 alongside greater than 1,500 influential leaders, to get to know these {industry} architects, pioneers and torchbearers face-to-face. Beneath is only a small number of the numerous industry-leading corporations supporting Hashish Europa 2025.
PHCANN Worldwide – Headline Sponsor
Hashish Europa 2025’s Headline Sponsor is PHCANN Worldwide, a number one multinational pharmaceutical hashish firm, underscoring its devotion to driving innovation, regulatory progress, and sustainable progress throughout the sector.
With a robust presence throughout Europe, PHCANN Worldwide continues to paved the way within the manufacturing and distribution of pharmaceutical-grade hashish merchandise, guaranteeing compliance with the best {industry} requirements. Their dedication to analysis, innovation, and affected person entry aligns completely with the aims of Hashish Europa.
“Being Headline Sponsor of Hashish Europa this 12 months is a pure extension of our purpose to drive significant conversations and foster strategic partnerships that may advance affected person entry and {industry} requirements. We stay up for partaking with thought leaders, policymakers, and {industry} pioneers as we collectively speed up the event of a sustainable and accountable hashish market in Europe,” stated Sasho Stefanoski, CEO of PHCANN Worldwide.
Mr Stefanoski will take to the primary stage on the second day of the convention to debate the evolution and way forward for EU-GMP necessities for world operators, and whether or not pharmaceutical requirements are really wanted for cultivation.
Vladimir Kofcegarski, Chief Gross sales Officer at PHCANN Worldwide, continued: “Our mission is to advance entry to high-quality, pharmaceutical-grade hashish merchandise throughout Europe, whereas collaborating with regulators, healthcare professionals, and {industry} stakeholders. This occasion gives an important alternative for us to try this.”
The Entourage Impact – Silver Sponsor
This 12 months’s convention will see extra delegates from the thriving Oceanic hashish markets of Australia and New Zealand than ever earlier than.
One such firm making its approach to the Barbican later this month might be The Entourage Impact, considered one of Australia’s main wholesalers of medicinal hashish merchandise.
Its founder, Eidan Havas, initially educated in prison legislation, however like most of the {industry}’s most passionate voices was launched to medical hashish by means of private, first hand expertise of its therapeutic potential.
Since its founding in 2022, The Entourage Impact has grown rapidly, increasing to a number of wholesale and distribution centres throughout the nation. MiDispensary, primarily based in New South Wales, is likely one of the state’s first specialist hashish clinics, providing tailor-made hashish remedies alongside MiPharmacy, which dispenses personalised medicines on to sufferers.
Mr Havas will be part of a panel on the second day of the convention to share insights from the Australian market on how Europe can obtain breakthroughs in affected person entry to succeed in 500,000 sufferers.
“The European hashish sector is quickly evolving, pushed by progressive regulatory modifications and growing funding in medical and wellness markets,” Mr Havas stated.
“Key gamers are specializing in high-quality, research-backed merchandise and constructing sturdy provide chains to fulfill rising affected person and shopper demand throughout numerous markets.”
The VOR Group – Silver Sponsor
Established simply final 12 months, the VOR Group are losing no time in introducing themselves to Europe’s hashish neighborhood.
The VOR Group is a UK-based well being and wellness firm specialising in superior hashish product improvement, distribution, and gross sales. The corporate develops revolutionary hashish formulations concentrating on ache, most cancers, psychological well being, and basic well-being.
Via its distribution operations, The VOR Group imports and provides worldwide hashish manufacturers to pharmacies and main UK retailers. Within the medical market, it imports and sells prescription hashish merchandise, constructing strategic world partnerships.
The corporate additionally owns and represents a portfolio of wellness manufacturers, with retail placements secured in main shops together with Holland & Barrett and Superdrug.
Linnea – Silver Sponsor
With over 40 years expertise Linnea’s intensive experience units the corporate aside and ensures high quality and innovation.
Since 1982 Linnea has been dedicated to prime quality botanical API manufacturing in our GMP licensed facility in Ticino Switzerland.
With a deal with sustainability and the atmosphere, Linnea is a number one pharmaceutical producer producing each botanical extracts & isolates and semi-synthetic APIs derived from botanicals
Avicanna – Silver Sponsor
Avicanna is a world biopharmaceutical firm devoted to the medical and pharmaceutical functions of cannabinoids. Below the management of founder and CEO Aras Azadian, the corporate has constructed a popularity for scientific innovation and medical excellence, with a strong pipeline of proprietary cannabinoid-based merchandise.
Since 2016, Mr Azadian and the Avicanna crew have navigated the complexities of world hashish regulation, driving ahead analysis, medical improvement, and commercialisation throughout a number of worldwide markets, at all times with a deal with evidence-based, data-driven innovation.
“Because the sector evolves and markets step by step liberalise, a transparent separation between adult-use and medical hashish corporations, their ethos and their focus, stays important. The following part of progress should not neglect sufferers or the important position of the medical neighborhood,” Mr Azadian stated.
He’ll be part of panellists on the primary stage on Wednesday to dive into these matters in additional element, discussing the important position of evidence-based merchandise, clinician training, and built-in assist programmes in incomes the belief of each sufferers and the medical neighborhood.
Cantourage UK – Silver Sponsor
Cantourage UK, a part of the Berlin-based European medical hashish powerhouse of the identical namesake, is out in drive at this 12 months’s occasion, with all three of its co-founders in attendance.
Niall Ivers, Chief Working Officer & Co-Founder, Gabriel Newman, Co-Founder & CEO, and Joshua Cuby, Co-Founder & Chief Gross sales Officer are collectively shortlisted for ‘Enterprise Chief of the Yr’ at this 12 months’s Enterprise of Hashish Awards, happening on the primary night of the occasion.
Our unbiased panel of judges have additionally shortlisted Cantourage UK for ‘Hashish Group of the Yr’ and ‘Hashish Clinic of the Yr’, in what is ready to be a memorable evening for all.
Mr Ivers, stated: “The European hashish sector is at a pivotal second, the chance is huge, however long-term success is determined by making a constructive suggestions loop for all stakeholders, particularly regulators. If they’ve a superb expertise, the entire {industry} thrives, and that’s how we construct a worthwhile, sustainable future.
His colleague, Mr Newman, might be exploring this matter and what place medical hashish has within the thriving wellness sector within the Greenhouse on the primary day of the occasion.
Elsewhere, Mr Cuby will participate in a panel dialogue on the primary stage on the identical day, delving into the position the UK is ready to play in ‘Europe’s Inexperienced Frontier’.
He commented: The… sector holds immense untapped potential, with data-driven insights and patient-reported outcomes poised to unlock the true therapeutic worth of this pure drugs. But progress stays hindered by fragmented regulation, restricted public consciousness, and cautious funding, maintaining us removed from realising its full promise.”
Develop Group – Silver Sponsor
Develop Group is a patient-first medical hashish firm, devoted to enhancing high quality of life for individuals who can profit from cannabinoid-based therapies.
Its passionate crew, which span medical, scientific and business experience, is led by CEO Pierre Van Weperen, who brings greater than 30 years of expertise within the pharmaceutical {industry}, and a private dedication to driving affected person outcomes.
Since becoming a member of GROW in 2019, he has led the corporate’s efforts to teach healthcare professionals, assist regulatory progress, and ship revolutionary services to sufferers and prescribers.
He’ll be heading up the primary panel of the convention, taking a a lot wider view of the problems at the moment dealing with the UK’s healthcare sector, with hundreds of thousands ready for analysis and remedy of situations equivalent to continual ache, endometriosis, ADHD, and PTSD, and the way medical hashish may provide an alternate answer.
Paralab – Bronze Sponsor
Paralab is a number one producer and provider of superior hashish post-harvest and extraction know-how, serving Europe, Israel, and Latin America.
Based by CEO Rui Soares, Paralab brings over 30 years of experience in extremely regulated pharmaceutical markets to the hashish sector, providing a full suite of EU-GMP compliant options throughout each stage of the hashish worth chain ,from bioburden management to extraction, purification, and packaging.
An ISO 9001:2015 licensed firm with an EU-GMP licensed laboratory and an R&D license for hashish merchandise, Paralab helps producers obtain precision, consistency, and suppleness in an more and more aggressive and numerous hashish market.
Mr Soares will be part of a panel of consultants on day two of the convention to debate the way forward for the hashish {industry}, and the rising applied sciences prone to form it, from small-batch and craft manufacturing strategies that cater to premium markets, to superior extraction improvements like microwave-assisted and ultrasound-assisted extraction that enhance each effectivity and product high quality.
Curaleaf Laboratories – Bronze Sponsor
Curaleaf Laboratories is the UK’s largest medical hashish processing facility and a trusted manufacturing and distribution companion for hashish corporations coming into or increasing within the UK market.
A part of the Curaleaf Worldwide group since 2019, Curaleaf Laboratories developed from Rokshaw, a well-established specials medicines producer with over a decade of experience in unlicensed medicines. At this time, it serves as a one-stop store for UK hashish manufacturers — providing versatile, EU-GMP-compliant manufacturing, high quality management, and scalable distribution throughout the nation.
Curaleaf Laboratories works with a variety of home and worldwide companions, offering packaging, labelling, and compliance experience that helps manufacturers navigate the UK’s evolving regulatory panorama. The corporate’s adaptable method, together with low minimal order portions and broad market entry by means of all UK clinics and pharmacies, allows companions to handle threat whereas responding to actual market demand.
At its core, Curaleaf Laboratories is dedicated to serving to the UK medical hashish sector thrive by means of collaboration, high quality, and patient-focused innovation. We’re excited to welcome them as a sponsor at Hashish Europa 2025, the place they proceed to champion a rising tide philosophy for the whole {industry}.
